Altox Bio Gets $24 Million to Fight Flesh Eating Disease

Atox Bio, an Israeli a clinical stage biotechnology company, has been awarded a $24 million contract to fight flesh eating diseases. No, such diseases are not something out of the Walking Dead which could More...

Infections treatment co Atox Bio raises $23 million

– Atox Bio will conduct a Phase II study for a soft tissue infections treatment. Atox Bio, which develops therapeutics for severe infections, has raised up to $23 million in a Series E investment More...